Cytta Announces Significant Additions to Management Team
Feb 13, 2017 13:02 pm UTC| Business
San Francisco, Feb. 13, 2017 -- February 13th, 2017 --Cytta Corp. (OTCPINK:CYCA) Cytta is excited to announce that the Company has added a significant new management team to our existing Officer group. Concurrent...
Cytta Announces Significant Additions to Management Team
Feb 13, 2017 13:02 pm UTC| Business
San Francisco, Feb. 13, 2017 -- February 13th, 2017 --Cytta Corp. (OTCPINK:CYCA) Cytta is excited to announce that the Company has added a significant new management team to our existing Officer group. Concurrent...
CSW Industrials Reports Fiscal Third Quarter 2017 Results
Feb 13, 2017 13:02 pm UTC| Business
Highlights Third quarter 2017 net revenue of $75.5 million, up 6.5% compared to $70.9 million in the prior year period.Third quarter 2017 GAAP operating income of $3.4 million; Non-GAAP operating income of $6.6...
CSW Industrials Reports Fiscal Third Quarter 2017 Results
Feb 13, 2017 13:02 pm UTC| Business
Highlights Third quarter 2017 net revenue of $75.5 million, up 6.5% compared to $70.9 million in the prior year period.Third quarter 2017 GAAP operating income of $3.4 million; Non-GAAP operating income of $6.6...
CSW Industrials Reports Fiscal Third Quarter 2017 Results
Feb 13, 2017 13:02 pm UTC| Business
Highlights Third quarter 2017 net revenue of $75.5 million, up 6.5% compared to $70.9 million in the prior year period.Third quarter 2017 GAAP operating income of $3.4 million; Non-GAAP operating income of $6.6...
Zogenix Announces Initiation of Clinical Efficacy Portion of Study 1504 for ZX008 in Dravet Syndrome
Feb 13, 2017 13:02 pm UTC| Business
Study 1504 Part of Phase 3 Program for ZX008 in Dravet Syndrome Safety and Efficacy Portion of Study Expanded from EU to Include Sites in U.S. and Canada EMERYVILLE, Calif., Feb. 13, 2017 -- Zogenix, Inc....
Zogenix Announces Initiation of Clinical Efficacy Portion of Study 1504 for ZX008 in Dravet Syndrome
Feb 13, 2017 13:02 pm UTC| Business
Study 1504 Part of Phase 3 Program for ZX008 in Dravet Syndrome Safety and Efficacy Portion of Study Expanded from EU to Include Sites in U.S. and Canada EMERYVILLE, Calif., Feb. 13, 2017 -- Zogenix, Inc....